J9217
HCPCSLeuprolide acetate suspnsion
Official HCPCS Level II long descriptor
Leuprolide acetate (for depot suspension), 7.5 mg
HCPCS Level II code J9217 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Leuprolide acetate suspnsion
Added to HCPCS: 1991-01-01
Nearby codes in J9
- J9208Ifosfamide injection
- J9209Mesna injection
- J9210Inj., emapalumab-lzsg, 1 mg
- J9211Idarubicin hcl injection
- J9213Interferon alfa-2a inj
- J9214Interferon alfa-2b inj
- J9215Interferon alfa-n3 inj
- J9216Interferon gamma 1-b inj
- J9218Leuprolide acetate injeciton
- J9219Leuprolide acetate implant
- J9220Indigotindisulfonate sod 1mg
- J9223Inj. lurbinectedin, 0.1 mg
- J9225Vantas implant
- J9226Supprelin la implant
- J9227Inj. isatuximab-irfc 10 mg
- J9228Ipilimumab injection
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.